A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients

NCT02605434 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Accordion Pill™ Carbidopa/Levodopa
DRUG: Sinemet®
DRUG: Placebo -AP-CD/LD
DRUG: Placebo- Sinemet

Sponsor

Intec Pharma Ltd.